Cerebral cortex pathology in aging and Alzheimer's disease: A quantitative survey of large hospital-based geriatric and psychiatric cohorts

Brain Research Reviews

Volumn 25, Issue 2, 1997, Pages 217-245

  Giannakopoulos, Panteleimon ^a   Hof, Patrick R ^b   Michel, Jean Pierre ^a   Guimon, José ^a   Bouras, Constantin ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid; Brain aging; Centenarian; Clinicopathologic correlation; Hippocampus; Neocortex; Neurofibrillary tangle

Indexed keywords

AGING; ALZHEIMER DISEASE; BRAIN CORTEX; DOWN SYNDROME; HISTOPATHOLOGY; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; SENILE PLAQUE;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID; ANIMALS; BRAIN; CEREBRAL CORTEX; DOWN SYNDROME; HUMANS; INPATIENTS; MEMORY DISORDERS; NEUROFIBRILLARY TANGLES; NEURONS;

EID: 0030780381     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00023-4     Document Type: Review

References (231)

1. Aletrino M.A., Vogels O.J.M., Van Domburg P.H.M.-F., Ten Donkelaar H.J. Cell loss in the nucleus raphe dorsalis in Alzheimer's disease. Neurobiol. Aging. 13:1992;461-468.
2. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex. 1:1991;103-116.
3. Arriagada P.V., Growdon J.H., Hedley-White E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
4. Arriagada P.V., Marzloff K., Hyman B.T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1992;1681-1688.
5. Asada T., Yamagata Z., Kinoshita T., Kinoshita A., Kariya T., Asaka A., Kakuma T. Prevalence of dementia and distribution of APOE alleles in Japanese centenarians: an almost-complete survey in Yamanashi prefecture, Japan. J. Am. Geriatrics Soc. 44:1996;151-155.
6. Baleydier C., Mauguière F. Network organization of the connectivity between parietal area 7, posterior cingulate cortex and medial pulvinar nucleus: a double fluorescent tracer study in monkey. Exp. Brain Res. 66:1987;385-393.
7. Ball M.J. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. Acta Neuropathol. 37:1977;111-118.
8. Benson D.F., Davis R.J., Snyder B.D. Posterior cortical atrophy. Arch. Neurol. 45:1988;789-793.
9. Berg L., McKeel D.W., Miller P., Baty J., Morris J.C. Neuropathological indexes of Alzheimer's disease in demented and ND persons aged 80 years and older. Arch. Neurol. 50:1993;349-358.
10. Bergmann M., Kuchelmeister K., Schmid K.W., Kretzschmar H.A., Schröder R. Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Acta Neuropathol. 92:1996;170-179.
11. Berthier M.L., Leiguarda R., Starkstein S.E., Sevlever G., Taratuto A.L. Alzheimer's disease in a patient with posterior cortical atrophy. J. Neurol. Neurosurg. Psychiatry. 54:1991;1110-1111.
12. Bierer L.M., Hof P.R., Purohit D.P., Carlin L., Schmeidler J., Davis K.L., Perl D.P. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52:1995;81-88.
13. Bondareff W., Mountjoy C.Q., Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology. 32:1982;164-168.
14. Bouras C., Giannakopoulos P., Shioi J., Tezapsidis N., Robakis N.K. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1185-1186.
15. Bouras C., Hof P.R., Giannakopoulos P., Michel J.P., Morrison J.H. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex. 4:1994;138-150.
16. Bouras C., Hof P.R., Morrison J.H. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci. Lett. 153:1993;131-135.
17. Braak H., Braak E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol. 68:1985;325-332.
18. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
19. Bramblett G.T., Trojanowski J.Q., Lee V.M.-Y. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Lab. Invest. 66:1992;212-222.
20. Brion J.P. Molecular pathology of Alzheimer amyloid and neurofibrillary tangles. Semin. Neurosci. 2:1990;89-100.
21. Brion J.P., Couck A.M., Bruce M., Anderton B., Flament-Durand J. Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease. Brain Res. 539:1991;143-150.
22. Brion J.P., Résibois A. A subset of calretinin-positive neurons are abnormal in Alzheimer's disease. Acta Neuropathol. 88:1994;33-43.
23. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology Arch. Gerontol. Geriatrics. 6:1987;193-208.
24. Brun A. Frontal lobe degeneration of non-Alzheimer type revisited. Dementia. 4:1993;126-131.
25. Buée-Scherrer V., Condamines O., Mourton-Gilles C., Jakes R., Goedert M., Pau B., Delacourte A. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol. Brain Res. 39:1996;79-88.
26. Buée-Scherrer V., Hof P.R., Buée L., Leveugle B., Vermersch P., Perl D.P., Olanow C.W., Delacourte A. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol. 91:1996;351-359.
27. Campbell M.J., Morrison J.H. A monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J. Comp. Neurol. 282:1989;191-205.
28. Cervós-Navarro J., Schumacher K. Neurofibrillary pathology in progressive supranuclear palsy (PSP). J. Neural Transm. 42(Suppl.):1994;153-164.
29. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1444.
30. Chin S.S.-M., Goldman J.E. Glial inclusions in CNS degenerative diseases. J. Neuropathol. Exp. Neurol. 55:1996;499-508.
31. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslop P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3:1997;67-72.
32. Cooper P.N., Jackson M., Lennox G., Lowe J., Mann D.M.A. τ, ubiquitin, and αB-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch. Neurol. 52:1995;1011-1015.
33. Copeland J.R.M., Davidson I.A., Dewey M.E., Gilmore C., Larkin B.A., McWilliam C., Saunders P.A., Scott A., Sharma V., Sullivan C. Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br. J. Psychiatry. 161:1992;230-239.
34. F.I.M. Craik, Age differences in remembering, in: L.R. Squire, N. Butters (Eds.), Neuropsychology of Memory, Guilford, New York, 1984, pp. 3-13.
35. Crook T., Bartus R.T., Ferris S.H., Whitehouse P., Cohen G.D., Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change - report of a National Institute of Mental Health Group. Dev. Neuropsychol. 4:1986;261-276.
36. Cruts M., Hendriks L., Van Broeckhoven C. The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum. Mol. Genet. 5:1996;1449-1455.
37. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M., Wolfson L. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 38:1988;1682-1687.
38. A.R. Damasio, Disorders of complex visual processing: agnosias, achromatopsias, Balint's syndrome and related difficulties of orientation and construction, in: M.M. Mesulam (Ed.), Principles of Behavioral Neurology, Contemporary Neurology Series, Vol. 26, F.A. Davis, Philadelphia, 1985, pp. 259-288.
39. De Lacoste M.C., White C.L. III The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol. Aging. 14:1993;1-16.
40. Delacourte A., Flament S., Dibe E.M., Hublau P., Sablonnière B., Hémon B., Scherrer V., Défossez A. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol. 80:1990;111-117.
41. Delacourte A., Robitaille Y., Sergeant N., Buée L., Hof P.R., Wattez A., Laroche-Cholette A., Mathieu J., Chagnon P., Gauvreau D. Specific pathological tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol. 55:1996;159-168.
42. Delaère P., He Y., Fayet G., Duyckaerts C., Hauw J.-J. Beta A4 deposits are constant in the brain of the oldest old: an immunohistochemical study of 20 French centenarians. Neurobiol. Aging. 14:1993;191-194.
43. Dewji N.N., Singer S.J. Specific transcellular binding between membrane proteins crucial to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 93:1993;12575-12580.
44. Diagnostic and Statistical Manual of Mental Disorders 4th edition, American Psychiatric Association, Washington, DC, 1994.
45. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.H., Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1991;179-189.
46. Dolan R.J., Tyrrell P.J., Frackowiak R.S.J. Oxygen metabolism in the dementias. J. Neural Transm. [Parkinson Dis. Dementia Spect.]. 1:1989;1-2.
47. Duyckaerts C., Hauw J.-J., Bastenaire F., Piette F., Poulain C., Rainsard V., Javoy-Agid F., Berthaux P. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol. 70:1986;249-256.
48. Esiri M.M., Pearson R.C.A., Powell T.P.S. The cortex of the primary auditory area in Alzheimer's disease. Brain Res. 366:1986;385-387.
49. D.A. Evans, P.A. Scherr, N.A. Cook, M.S. Albert, H.H. Funkenstein, L.A. Beckett, L.E. Hebert, T.T. Wetle, L.G. Branch, M.J. Chown, C.H. Hennekens, J.O. Taylor, The impact of Alzheimer's disease in the United States population, in: R.M. Suzman, D.P. Willis, K.G. Manton (Eds.), The Oldest-Old, Oxford University Press, New York, 1992, pp. 283-299.
50. Evans J.J., Heggs A.J., Antoun N., Hodges J.R. Progressive prosopoagnosia associated with selective right temporal lobe atrophy: A new syndrome? Brain. 118:1996;1-13.
51. Fallet-Bianco C., Roudier M., Lamour Y., Davous P. Etude neuropathologique de 50 cas de démence sénile. Rev. Neurol. 146:1990;687-696.
52. Feany M.B., Mattiace L.A., Dickson D.W. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 55:1996;53-67.
53. Feany M.B., Ksiezak-Reding H., Liu W.K., Vincent I., Yen S.H.C., Dickson D.W. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol. 90:1996;37-43.
54. Feany M.B., Dickson D.W. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am. J. Pathol. 146:1995;1388-1393.
55. Flament S., Delacourte A., Delaère P., Duyckaerts C., Hauw J.-J. Correlation between microscopical changes and tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol. 80:1990;212-215.
56. Flament S., Delacourte A., Mann D.M.A. Phosphorylation of tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Res. 516:1990;15-19.
57. Flament S., Delacourte A., Verny M., Hauw J.-J., Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy; similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol. 81:1991;591-596.
58. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 12:1975;189-198.
59. Fratiglioni L., Grut M., Forsell Y., Viitanen M., Grafstrom M., Holmen K., Ericsson K., Backman L., Ahlbom A., Winblad B. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology. 41:1991;1886-1892.
60. Fratiglioni L., Grut M., Forsell Y., Viitanen M., Winblad B. Clinical diagnosis of Alzheimer's disease and other dementias in a population survey: agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders Criteria, Revised Third Edition. Arch. Neurol. 49:1992;927-932.
61. Gabriel M., Foster K., Orona E., Saltwick S.E., Stanton M. Neuronal activity of cingulate cortex, anteroventral thalamus, and hippocampal formation in discriminative conditioning: encoding and extraction of the significance of conditional stimuli. Prog. Psychobiol. Physiol. Psychol. 9:1980;125-131.
62. Gaspar P., Duyckaerts C., Febvret A., Benoit R., Beck B., Berger B. Subpopulations of somatostatin 28-immunoreactive neurons display differential vulnerability in senile dementia of the Alzheimer type. Brain Res. 490:1989;1-13.
63. Gazzaley A.H., Siegel S.J., Kordower J.H., Mufson E.J., Morrison J.H. Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;3121-3125.
64. Giannakopoulos P., Bouras C., Kövari E., Shioi J., Tezapsidis N., Hof P.R., Robakis N.K. Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer disease. Am. J. Pathol. 150:1997;429-436.
65. Giannakopoulos P., Hof P.R., Bouras C. Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases. Acta Neuropathol. 89:1995;346-355.
66. Giannakopoulos P., Hof P.R., Giannakopoulos A.-S., Buée-Scherrer V., Surini M., Delacourte A., Bouras C. Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia. 5:1994;348-356.
67. Giannakopoulos P., Hof P.R., Giannakopoulos A.-S., Hermann F., Michel J.-P., Bouras C. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch. Neurol. 52:1995;1150-1159.
68. Giannakopoulos P., Hof P.R., Kövari E., Vallet P.G., Bouras C. Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J. Neuropathol. Exp. Neurol. 55:1996;1120-1210.
69. Giannakopoulos P., Hof P.R., Mottier S., Michel J.-P., Bouras C. Neuropathologic changes in the neocortex of 1258 cases from a geriatric hospital: retrospective clinicopathologic evaluation of a ten year autopsy population. Acta Neuropathol. 87:1994;456-468.
70. Giannakopoulos P., Hof P.R., Surini M., Michel J.-P., Bouras C. Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol. 85:1993;601-610.
71. Giannakopoulos P., Hof P.R., Vallet P.G., Giannakopoulos A.-S., Charnay Y., Bouras C. The quantitative analysis of neuropathological changes in the cerebral cortex of centenarians. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 19:1994;577-592.
72. Giannakopoulos P., Hof P.R., Savioz A., Guimon J., Antonarakis S.E., Bouras C. Early-onset dementias: clinical, neuropathological and genetic characteristics. Acta Neuropathol. 91:1996;451-465.
73. Giannakopoulos P., Hof P.R., Bouras C. Age versus ageing as a cause of dementia. Lancet. 346:1995;1486.
74. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulfated glycosaminoglycans. Nature. 383:1996;550-553.
75. Gómez-Isla T., Price J.L., McKeel Jr D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
76. Hänninen T., Hallikainen M., Koivisto K., Helkala E.L., Reinikainen K.J., Soininen H., Mykkanen L., Laakso M., Pyorala K., Riekkinen P.J. Sr. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J. Am. Geriatrics Soc. 43:1995;1007-1015.
77. Hansen L.A., DeTeresa R., Davies P., Terry R.D. Neocortical morphometry, lesion counts, and choline acetyltransferance levels in the age spectrum of Alzheimer's disease. Neurology. 38:1988;48-54.
78. Hardy J. Alzheimer's disease: the present situation and our tasks. Neurobiol. Aging. 15:1994;S111-S112.
79. Hauw J.-J., Vignolo P., Duyckaerts C., Beck H., Forette F., Henry J.F., Laurent M., Piette F., Sachet A., Berthaux P. Etude neuropathologique de 12 centenaires: la fréquence de la démence sénile de type Alzheimer n'est pas particulièrement élevée dans ce groupe de personne très agées. Rev. Neurol. 142:1986;107-115.
80. Hauw J.-J., Daniel S.E., Dickson D., Horoupian D.S., Jellinger K., Lantos P.L., McKee A., Tabaton M., Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 44:1994;2015-2019.
81. Haxby J.V., Grady C.L., Duara R., Schlageter N., Berg G., Rapoport S. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch. Neurol. 43:1986;882-885.
82. Haxby J.V., Grady C.L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R.P., Rapoport S. Longitudinal studies of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760.
83. Hayes T.L., Lewis D.A. Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex. Cereb. Cortex. 2:1992;56-67.
84. Hendriks L., Van Broeckhoven C. The βA4 amyloid precursor protein gene and Alzheimer's disease. Eur. J. Biochem. 237:1996;6-15.
85. Heyman A., Wilkinson W.E., Hurwitz B.L., Helms M.J., Haynes C.S., Utley C.M., Gwyther L.P. Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology. 83:1987;170-178.
86. Hof P.R., Archin N., Osmand A.P., Dougherty G.H., Wells C., Bouras C., Morrison J.H. Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of an historical report. Acta Neuropathol. 86:1993;215-223.
87. Hof P.R., Bierer L.M., Perl D.P., Delacourte A., Buée L., Bouras C., Morrison J.H. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia - Regional and laminar distribution of neurofibrillary tangles and senile plaques. Arch. Neurol. 49:1992;946-953.
88. Hof P.R., Bouras C. Object recognition deficit in Alzheimer's disease: possible disconnection of the occipito-temporal component of the visual system. Neurosci. Lett. 122:1991;53-56.
89. Hof P.R., Bouras C., Constantinidis J., Morrison J.H. Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway. Brain Res. 493:1989;368-375.
90. Hof P.R., Bouras C., Constantinidis J., Morrison J.H. Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J. Neuropathol. Exp. Neurol. 49:1990;168-184.
91. Hof P.R., Bouras C., Perl D.P., Morrison J.H. Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol. 87:1994;115-124.
92. Hof P.R., Cox K., Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. I. Superior frontal and inferior temporal cortex J. Comp. Neurol. 301:1990;44-54.
93. Hof P.R., Cox K., Young W.G., Celio M.R., Rogers J., Morrison J.H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 50:1991;451-462.
94. Hof P.R., Giannakopoulos P., Vickers J.C., Bouras C., Morrison J.H. The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution, and vulnerable neuronal phenotype. Rev. Neurosci. 6:1995;97-124.
95. Hof P.R., Morrison J.H. Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: a quantitative immunohistochemical analysis. J. Comp. Neurol. 352:1995;161-186.
96. Hof P.R., Nimchinsky E.A., Morrison J.H. Neurochemical phenotype of corticocortical connections in the macaque monkey: quantitative analysis of a subset of neurofilament protein-immunoreactive projection neurons in frontal, parietal, temporal, and cingulate cortices. J. Comp. Neurol. 362:1996;109-133.
97. Hof P.R., Bouras C., Perl D.P., Sparks L., Mehta N., Morrison J.H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Arch. Neurol. 52:1995;379-391.
98. Hof P.R., Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. II. Primary and secondary visual cortex J. Comp. Neurol. 301:1990;55-64.
99. Hof P.R., Morrison J.H. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp. Neurol. 111:1991;293-301.
100. P.R. Hof, J.H. Morrison, The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions, in: R.D. Terry, R. Katzman, K.L. Bick (Eds.), Alzheimer Disease, Raven, New York, 1994, pp. 197-229.
101. Hof P.R., Nimchinsky E.A., Celio M.R., Bouras C., Morrison J.H. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci. Lett. 152:1993;145-149.
102. Hof P.R., Morrison J.H. Hippocampal and neocortical involvement in normal brain aging and dementia: morphologic and neurochemical profile of the vulnerable circuits. J. Am. Geriat. Soc. 44:1996;857-864.
103. Hof P.R., Giannakopoulos P., Bouras C. The neuropathological changes associated with normal brain aging. Histol. Histopathol. 11:1996;1075-1088.
104. P.R. Hof, B.A. Vogt, C. Bouras, J.H. Morrison, Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways, Vision Res., 1997, in press.
105. Hofman A., Rocca W.A., Brayne C., Breteler M.M.B., Clarke M., Cooper B., Copeland J.R.M., Dartigues J.F., Da Silva-Droux A., Hagnell O., Heeren T.J., Engedal K., Jonker C., Lindesay J., Lobo A., Mann A.H., Mölsä P.K., Morgan K., O'Connor D.W., Sulkava R., Kay D.W.K., Amaducci L. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int. J. Epidemiol. 20:1991;736-748.
106. Hubbard B.M., Fenton G.W., Anderson J.M. A quantitative histological study of early clinical and preclinical Alzheimer's disease. Neuropathol. Appl. Neurobiol. 16:1990;111-121.
107. Hyman B.T., Damasio A.R., Van Hoesen G.W., Barnes C.L. Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170.
108. Hyman B.T., Van Hoesen G.W., Damasio A.R. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann. Neurol. 22:1987;37-40.
109. Hyman B.T., Van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology. 40:1990;1721-1730.
110. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
111. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., Shearman M.S. The toxicity in vitro of β-amyloid protein. Biochem. J. 311:1995;1-16.
112. Iwatsubo T., Saido T.C., Mann D.M.A., Lee V.M.-Y., Trojanowski J.Q. Full-length amyloid-β (1-42(43)) and amino-terminally modified and truncated amyloid β42(43) deposit in diffuse plaques. Am. J. Pathol. 149:1996;1823-1830.
113. Jacquet M.F., Boucquey D., Theaux R., Smidts M., Callewaert A., Brucher J.M., Kevers L. L'atrophie corticale postérieure: variante anatomo-clinique de la maladie d'Alzheimer. Acta Neurol. Belg. 90:1990;265-273.
114. Jorm A.F. Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. Eur. Arch. Psychiatry Clin. Neurosci. 240:1991;218-222.
115. A.W. Kaszniak, L.W. Poon, W. Riege, Assessing memory deficits: an information-processing approach, in: L.W. Poon (Ed.), Clinical Memory Assessment of Older Adults, American Psychological Association, Washington, DC, 1986, pp. 168-188.
116. R. Katzman, C. Kawas, The epidemiology of dementia and Alzheimer's disease, in: R. Katzman, K.L. Bick (Eds.), Alzheimer Disease, Raven, New York, 1994, pp. 105-122.
117. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X., Peck A. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23:1988;138-144.
118. R. Katzman, R. Terry, Normal aging of the nervous system, in: R. Katzman, R.D. Terry (Eds.), The Neurology of Aging, Davis, Philadelphia, 1983, pp. 15-50.
119. Kertesz A., Hudson L., Mackenzie I.R.A., Munoz D.G. The pathology and nosology of primary progressive aphasia. Neurology. 44:1994;2065-2072.
120. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
121. Kim K.S., Miller D.L., Sapienza V.G., Chen C.C.J., Vai C., Grundke-Iqbal I., Curry J.R., Wisniewski H.M. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2:1988;121-130.
122. Koivisto K., Reinikainen K.J., Hänninen T., Vanhanen M., Helkala E.-L., Mykkänen L., Laakso M., Pyörälä K., Riekkinen P.J. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology. 45:1995;741-747.
123. Ksiezak-Reding H., Morgan K., Mattiace L.A., Davies P., Liu W.K., Yen S.H., Weidenheim K., Dickson D.W. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am. J. Pathol. 145:1994;1496-1508.
124. Kukull W.A., Larson E.B., Reifler B.V., Lampe T.H., Yerby M., Hughes J. Interrater reliability of Alzheimer's disease diagnosis. Neurology. 40:1990;257-260.
125. Larrabee G.J., McEntee W.J. Age-associated memory impairment: Sorting out the controversies. Neurology. 45:1995;611-614.
126. Lautenschlager N.T., Cupples L.A., Rao V.S., Auerbach S.A., Becker R., Burke J., Chui H., Duara R., Foley E.J., Glatt S.L., Green R.C., Jones R., Karlinsky H., Kukull W.A., Kurz A., Larson E.B., Martelli K., Sadovnick A.D., Volicer L., Waring S.C., Growdon J.H., Farrer L.A. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology. 46:1996;641-650.
127. Lee V.M.-Y., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251:1991;675-678.
128. Levine D.N., Lee J.M., Fisher C.M. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology. 43:1993;305-313.
129. Lewis D.A., Campbell M.J., Terry R.D., Morrison J.H. Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J. Neurosci. 7:1987;1799-1808.
130. Lippa C.F., Hamos J.E., Pulaski-Salo D., Degennaro L.G., Drachman D.A. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol. Aging. 13:1992;405-411.
131. Litvan I., Hauw J.-J., Bartko J.J., Lantos P.L., Daniel S.E., Horoupian D.S., McKee A., Dickson D., Bancher C., Tabaton M., Jellinger K., Anderson D.W. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J. Neuropathol. Exp. Neurol. 55:1996;97-105.
132. Lopez O.L., Swihart A.A., Becker J.T., Reinmuth O.M., Reynolds C.F. III, Rezek D.L., Daly F.L. III Reliability of NINDCS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology. 40:1990;1517-1522.
133. Mann D.M.A., Brown A.M.T., Prinja D., Jones D., Davies C.A. A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol. Appl. Neurobiol. 16:1990;17-25.
134. Mann D.M.A., South P.W., Snowden J.S., Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J. Neurol. Neurosurg. Psychiatry. 56:1993;605-614.
135. Mann D.M.A., Iwatsubo T., Ihara Y., Cairns N.J., Lantos P.L., Bogdanovic N., Lannfelt L., Winblad B., Maat-Schieman M.L.C., Rossor M.N. Predominant deposition of amyloid-beta (42(43)) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am. J. Pathol. 148:1996;1257-1266.
136. Masliah E., Mallory M., Hansen L., DeTeresa R., Terry R.D. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology. 43:1993;192-197.
137. Masliah E., Terry R.D., Aldorf M., DeTeresa R.M., Hansen L.A. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer disease. Am. J. Pathol. 138:1991;235-246.
138. 14C]2-deoxy-D-glucose uptake into retrosplenial cortex and other memory-related structures of the monkey during a delayed response. Brain Res. Bull. 22:1989;829-838.
139. Matsuo S.E., Shi R.W., Billingsley M.L., Van de Voorde A., O'Connor M., Trojanowski J.Q., Lee V.M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
140. Maury C.P.J. Molecular pathogenesis of beta-amyloidosis in Alzheimer's disease and other cerebral amyloidosis. Lab, in:vest. 72:1995;4-16.
141. McKeith I.G., Galasko D., Wilcock G.K., Byrne E. Lewy body dementia - diagnosis and treatment. Br. J. Psychiatry. 167:1995;709-717.
142. McKenzie J.E., Edwards R.J., Gentleman S.M., Ince P.G., Perry R.H., Royston M.-C., Roberts G.W. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. Acta Neuropathol. 91:1996;526-529.
143. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINDCS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
144. McMillan P.J., Leverenz J.B., Poorkaj P., Schellenberg G.D., Dorsa D.M. Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease. J. Histochem. Cytochem. 44:1996;1215-1222.
145. Mentis M.J., Horwitz B., Grady C.L., Alexander G.E., VanMeter J.W., Maisog J.-M., Pietrini P., Schapiro M.B., Rapoport S.I. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded 'stress test' during PET. Am. J. Psychiatry. 153:1996;32-40.
146. Messa C., Perani D., Lucignani G., Zenorini A., Zito F., Rizzo G., Grassi F., Del-Sole A., Franceschi M., Gilardi M.C., Fazio F. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. J. Nucl. Med. 35:1994;210-216.
147. Meunier M., Bachevalier J., Mishkin M., Murray E.A. Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys. J. Neurosci. 13:1993;5418-5432.
148. Minoshima S., Foster N.L., Kuhl D.E. Posterior cingulate cortex in Alzheimer's disease. Lancet. 344:1994;895.
149. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology. 41:1991;479-486.
150. T. Mizutani, H. Shimada, Neuropathological aspects of centenarian brains: study of 24 autopsy cases, in: K. Hasegawa, A. Homma (Eds.), Psychogeriatrics - Biomedical and Social Advances, Excerpta Medica, Tokyo, 1990, pp. 128-133.
151. Mizutani T., Shimada H. Neuropathological background of twenty-seven centenarian brains. J. Neurol. Sci. 108:1992;168-177.
152. Mölsä P.K., Marttila R.J., Rinne U.K. Epidemiology of dementia in a Finnish population. Acta Neurol. Scand. 65:1982;541-552.
153. Morecraft R.J., Van Hoesen G.W. Cingulate input to the primary and supplementary motor cortices in the rhesus monkey: evidence for somatotopy in areas 24 and 23c. J. Comp. Neurol. 322:1992;471-489.
154. Morris J.C., McKeel J.D.W., Storandt M., Rubin E.H., Price J.L., Grant E.A., Ball M.J., Berg L. Very mild Alzheimer's disease: informant-based
155. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:1986;774-776.
156. Morrison J.H. Differential vulnerability, connectivity, and cell typology. Neurobiol. Aging. 14:1993;51-54.
157. Morrison J.H., Lewis D.A., Campbell M.J., Huntley G.W., Benson D.L., Bouras C. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res. 416:1987;331-336.
158. J.A. Mortimer, L.M. Schuman, L.R. French, Epidemiology of dementing illness, in: J.A. Mortimer, L.M. Schuman (Eds.), The Epidemiology of Dementia, Oxford University Press, New York, 1981, pp. 3-23.
159. M. Moss, M. Albert, Alzheimer's disease and other dementing disorders, in: M. Albert, M. Moss (Eds.), Geriatric Neuropsychology, Guilford, New York, 1988, pp. 145-177.
160. Mountjoy C.Q., Roth M., Evans N.J.R., Evans H.M. Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging. 4:1983;1-11.
161. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
162. Nimchinsky E.A., Hof P.R., Young W.G., Morrison J.H. Neurochemical, morphologic and laminar characterization of cortical projection neurons in the cingulate motor areas of the macaque monkey. J. Comp. Neurol. 374:1996;136-160.
163. O'Banion M.K., Coleman P.D., Callahan L.M. Regional neuronal loss in aging and Alzheimer's disease: a brief review. Semin. Neurosci. 6:1994;307-314.
164. Ohm T.G., Braak H. Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol. 73:1987;365-369.
165. Olson C.R., Musil S.Y. Topographic organization of cortical and subcortical projections to posterior cingulate cortex in the cat: evidence for somatic, ocular, and complex subregions. J. Comp. Neurol. 324:1992;237-260.
166. C.R. Olson, S.Y. Musil, M. Goldberg, Posterior cingulate cortex and visuospatial cognition: properties of single neurons in the behaving monkey, in: B.A. Vogt, M. Gabriel (Eds.), The Neurobiology of Cingulate Cortex and Limbic Thalamus, Birkhäuser, Boston, 1993, pp. 336-380.
167. Oyama F., Cairns N.J., Shimada H., Oyama R., Titani K., Ihara Y. Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J. Neurochem. 62:1994;1062-1066.
168. Paganinihill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer's disease. Arch. Intern. Med. 156:1996;2213-2217.
169. Pardo J.V., Pardo P.J., Janer K.W., Raichle M.E. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc. Natl. Acad. Sci. USA. 87:1990;256-259.
170. 1H)-MRS, MRI-based hippocampal volumetry, and (99m)TC-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J. Am. Geriatrics Soc. 44:1996;133-138.
171. Paulus W., Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol. 81:1990;89-94.
172. Pearson R.C.A., Esiri M.M., Hiorns R.W., Wilcock G.K., Powell T.P.S. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 82:1985;4531-4534.
173. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., Kokmen E., Waring S.C., Kurland L.T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. J. Am. Med. Assoc. 273:1995;1274-1278.
174. Pietrini P., Furey M.L., Graff-Radford N., Freo U., Alexander G.E., Grady C.L., Dani A., Mentis M.J., Schapiro M.B. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am. J. Psychiatry. 153:1996;1261-1268.
175. L.W. Poon, Differences in human memory with aging: nature, causes and implications, in: E. Birren, W. Schaie (Eds.), Handbook of the Psychology of Aging, Van Nostrand Reinhold, New York, 1985, pp. 427-462.
176. Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 12:1991;295-312.
177. Rebeck G.W., Perls T.T., West H.L., Sodhi P., Lipsitz L.A., Hyman B.T. Reduced apolipoprotein e4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 44:1994;1513-1516.
178. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N. Engl. J. Med. 334:1996;752-758.
179. Richey P.L., Siediak S.L., Smith M.A., Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Biochem. Biophys. Res. Commun. 208:1995;657-663.
180. Riley D.E., Lang A.E., Lewis A., Resch L., Ahsby P., Hornykiewicz O., Black S. Cortico-basal ganglionic degeneration. Neurology. 40:1990;1203-1212.
181. Rinne J.O., Lee M.S., Thompson P.D., Marsden C.D. Corticobasal degeneration: a clinical study of 36 cases. Brain. 117:1994;1183-1196.
182. Ritchie K., Kildea D. Is senile dementia 'age-related' or 'ageing-related'? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 346:1995;931-933.
183. N.K. Robakis, β-amyloid and amyloid precursor protein: chemistry, molecular biology, and neuropathology, in: R.D. Terry, R. Katzman, K.L. Bick (Eds.), Alzheimer Disease, Raven, New York, 1994, pp. 317-326.
184. Rogers J., Morrison J.H. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J. Neurosci. 5:1985;2801-2808.
185. Roses A.D. The Alzheimer diseases. Curr. Opin. Neurobiol. 6:1996;644-650.
186. Samuel W., Galasko D., Masliah E., Hansen L.A. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;44-52.
187. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
188. Senut M.C., Roudier M., Davous P., Fallet-Bianco C., Lamour Y. Senile dementia of the Alzheimer type: is there a correlation between entorhinal cortex and dentate gyrus? Acta Neuropathol. 82:1996;306-315.
189. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 89:1997;629-639.
190. Small G.W., LaRue A., Komo S., Kaplan A., Mandelkern M.A. Predictors of cognitive changes in middle-aged and older adults with memory loss. Am. J. Psychiatry. 152:1995;1757-1764.
191. Sobel E., Louhija J., Sulkava R., Davanipour Z., Kontula K., Miettinen H., Tikkanen M., Kainulainen K., Tilvis R. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 45:1995;903-907.
192. Squire L.R., Zola-Morgan S. The medial temporal lobe memory system. Science. 253:1991;1380-1386.
193. Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J. Microsc. 134:1984;127-136.
194. Sutherland R.J., Whishaw I.Q., Kolb B. Contributions of cingulate cortex to two forms of spatial learning and memory. J. Neurosci. 8:1988;1863-1872.
195. Suzuki W.A., Zola-Morgan S., Squire L.R., Amaral D.G. Lesions of the perirhinal and parahippocampal cortices in the monkey produce long-lasting impairment in the visual and tactile modalities. J. Neurosci. 13:1993;2430-2451.
196. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogens during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
197. Terry R.D., Hansen L.A., DeTeresa R., Davies P., Tobias H., Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangle. J. Neuropathol. Exp. Neurol. 46:1987;262-268.
198. R.D. Terry, E. Masliah, L.A. Hansen, Structural basis of the cognitive alterations in Alzheimer disease, in: R.D. Terry, R. Katzman, K.L. Bick (Eds.), Alzheimer Disease, Raven, New York, 1994, pp. 179-196.
199. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:1991;572-580.
200. Terry R.D., Peck A., DeTeresa R., Schechter R., Horoupian D.S. Some morphometric aspects of the brain in senile dementia of the Alzheimer's type. Ann. Neurol. 10:1981;184-192.
201. R.D. Terry, H.M. Wisniewski, The ultrastructure of the neurofibrillary tangle and the senile plaque, in: G.E.W. Wolstenholme, M. O'Connor (Eds.), CIBA Foundation Symposium on Alzheimer's Disease and Related Conditions, J. & A. Churchill, London, 1970, pp. 145-155.
202. Tolnay M., Probst A. Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol. Appl. Neurobiol. 21:1995;492-497.
203. B.E. Tomlinson, Morphological brain changes in non-demented old people, in: H.M. Van Praag, A.K. Kalverboer (Eds.), Aging of the Nervous System, DeErvon-Bohn, New York, 1972, pp. 44-55.
204. Tomlinson B.E., Blessed G., Roth M. Observations on the brains of ND old people. J. Neurol. Sci. 7:1968;331-356.
205. Trojanowski J.Q., Schmidt M.L., Shin R.W., Bramblett G.T., Rao D., Lee V.M.-Y. Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3:1993;45-54.
206. Ulrich J. Alzheimer changes in non-demented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann. Neurol. 17:1985;273-277.
207. US Congress, Office of Technology Assessment, Losing a Million Minds: Confronting the tragedy of Alzheimer's disease and other dementias, Government Printing Office, Washington DC, 1987, Publication OTA BA-323.
208. Vallet P.G., Guntern R., Hof P.R., Golaz J., Delacourte A., Robakis N.K., Bouras C. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol. 83:1992;170-178.
209. Van Broeckhoven C.L., Backhovens H., Cruts M., De Winter G., Bruyland M., Cras P., Martin J. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nature Genet. 2:1992;335-339.
210. Van Broeckhoven C.L. Presenilins and Alzheimer's disease. Nature Genet. 11:1995;230-232.
211. Vermersch P., David J.P., Frigard B., Fallet-Bianco C., Wattez A., Petit H., Delacourte A. Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 19:1995;1035-1047.
212. Vermersch P., Frigard B., David J.P., Fallet-Bianco C., Delacourte A. Presence of abnormally phosphorylated tau proteins in the entorhinal cortex of aged non-demented subjects. Neurosci. Lett. 144:1992;143-146.
213. Vermersch P., Frigard B., Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol. 85:1992;48-54.
214. Vickers J.C., Delacourte A., Morrison J.H. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res. 594:1992;273-278.
215. Vickers J.C., Riederer B.M., Marugg R.A., Buée-Scherrer V., Buée L., Delacourte A., Morrison J.H. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience. 62:1994;1-13.
216. Vickers J.C., Chin D., Edwards A.M., Sampson V., Harper C., Morrison J.H. Dystrophic neurite formation associated with age-related β amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology. Exp. Neurol. 141:1996;1-11.
217. Vogels O.J.M., Broere A.J., Ter Laak H.J., Ten Donkelaar H.J., Nieuwenhuys R., Schulte B.P.M. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging. 11:1990;3-13.
218. Vogt B.A., Rosene D.L., Pandya D.N. Thalamic and cortical afferents differentiate anterior from posterior cingulate cortex in the monkey. Science. 204:1979;205-207.
219. Vogt B.A., Pandya D.N. Cingulate cortex of rhesus monkey. II. Cortical afferents J. Comp. Neurol. 262:1987;271-289.
220. Vogt B.A., Van Hoesen G.W., Vogt L.J. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol. 80:1990;581-589.
221. Watson R.T., Heilman K.M., Cauthen J.C., King F.A. Neglect after cingulectomy. Neurology. 23:1973;1003-1007.
222. West M.J. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging. 14:1993;287-293.
223. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 344:1994;769-772.
224. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
225. Wisniewski T., Castaño E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1994;1030-1035.
226. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
227. Wisniewski T., Palha J.A., Ghiso J., Frangione B. S182 protein in Alzheimer's disease neuritic plaques. Lancet. 346:1995;1366.
228. Wolfe N., Reed B.P., Eberling J.L., Jagust W.J. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch. Neurol. 52:1995;257-262.
229. Zola-Morgan S., Squire L.R. Preserved learning in monkeys with medial temporal lesions: sparing of motor and cognitive skills. J. Neurosci. 4:1984;1072-1085.
230. Zola-Morgan S., Squire L.R., Amaral D.G., Suzuki W.A. Lesions of perirhinal and parahippocampal cortex that spare the amygdala and hippocampal formation produce severe memory impairment. J. Neurosci. 9:1989;4355-4370.
231. Zola-Morgan S., Squire L.R., Rempel N.L., Clower R.P., Amaral D.G. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J. Neurosci. 12:1992;2582-2596.